Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 20:10:138.
doi: 10.3389/fpsyt.2019.00138. eCollection 2019.

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

Ben Sessa  1 , Laurie Higbed  1 , David Nutt  1
Affiliations
Review

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

Ben Sessa et al. Front Psychiatry. .

Abstract

This paper provides a brief review of the history, proposed pharmacological mechanisms, safety issues, and clinical applications of the medicine 3,4-methylenedioxymethamphetamine (MDMA). Most clinical MDMA research in patients to date has focused on MDMA-assisted psychotherapy to treat posttraumatic stress disorder (PTSD). In this review paper other potential therapeutic applications for MDMA therapy are described, including contemporary studies treating anxiety associated with autism and the authors' ongoing study exploring the potential role for MDMA-assisted psychotherapy to treat alcohol use disorder. MDMA therapy for PTSD is now entering the final Phase 3 stage of drug development, with a target set for licensing by the FDA and EMA in 2021. This means that if clinical efficacy criteria are achieved, MDMA would become a medicine.

Keywords: 4-methylenedioxymethamphetamine); MDMA (3; addiction; alcohol; psychotherapy; trauma.

PubMed Disclaimer

References

    1. Shulgin A. 3-methoxy-4,5-methylenedioxy amphetamine, a new psychotomimetic agent. Nature. (1964) 201:1120–1. 10.1038/2011120a0 - DOI - PubMed
    1. Stolaroff M. The secret chief revealed: conversations with a pioneer of the underground therapy movement. Sarasota: Multidisciplinary Association for Psychedelic Studies (2004).
    1. Shulgin AT, Nichols DE. Characterization of Three New Psychotomimetcs. In: Stillman RC, Willette RE, editors. The Psychopharmacology of Hallucinogens. New York, NY: Pergamon Press; (1978).
    1. Nichols DE. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs. (1986) 18:305–13. 10.1080/02791072.1986.10472362 - DOI - PubMed
    1. Sessa B. Could MDMA be useful in the treatment of PTSD? Prog Neurol Psychiatry. (2012) 15:4–7. 10.1002/pnp.216 - DOI